Skip to content

Assessing the Safety & Efficacy of an Affordable Fracture External Fixation System

AEFIX Trial: A Multicenter Randomized Controlled Trial Assessing Safety and Efficacy of a Novel, Affordable Fracture External Fixation System

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
PACTR
Registry ID
PACTR202510646012532
Enrollment
150
Registered
2025-10-20
Start date
2026-06-01
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Injury, Occupational Diseases, Poisoning Surgery Orthopaedics

Interventions

AEFIX external fixation system
Locally available external fixation

Sponsors

Harvard Global Orthopaedics Collaborative
Lead Sponsor
SONA Global
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients 18 years of age or older. 2. Closed or open fractures of the femur and/or tibia, including fractures of the proximal femur, femoral diaphysis, extra-articular and intra-articular fractures of the distal femur and proximal tibia, tibia diaphysis, and extra-articular and intra-articular fractures of the distal tibia including pilon and ankle fractures. 3. Fractures not amenable to internal fixation due to risk of infection, inadequate soft tissue coverage, severe soft tissue trauma, or patient hemodynamic instability, and therefore indicated for external fixation by the treating surgeon. 4. A participating surgeon or delegate at a study site will perform all planned surgeries (i.e. there is no pre-operative plan for the patient to be transferred into another facility/surgeon’s care after external fixation is performed). 5. Informed consent obtained.

Exclusion criteria

Exclusion criteria: 1. Patients with established fracture malunions or nonunions, including any patient undergoing correction of deformity, management of a malunion, nonunion, or delayed union. 2. Patients with established chronic osteomyelitis or pathologic fractures. 3. Patients undergoing limb deformity correction or bone transport. 4. Patients with periprosthetic fractures. 5. Patient incarceration. 6. Patients currently enrolled in another study that does not permit co-enrollment. 7. Unable to obtain informed consent due to language barriers. 8. Prior enrollment in this study.

Design outcomes

Primary

MeasureTime frame
maintenance of fracture reduction as measured on initial post-operative and subsequent radiographs after application of external fixation until removal. X-rays will be taken within 24 hours after the initial surgery during which external fixation, either AEFIX or the locally available devices, would have been applied by the treating surgeon. X-rays will be repeated a maximum of 48 hours prior to removal of the external fixator construct, with or without conversion to internal fixation. Any x-rays taken between external fixator application and removal shall also be recorded in the electronic data collection system. Fracture reduction will be compared between the initial and subsequent x-rays. Fracture alignment and angulation, and any fracture gap will be measured and compared between x-rays. The degree of fracture displacement shall be compared between the treatment arms.

Secondary

MeasureTime frame
Frequency of clinical complications (pin tract infections, superficial/deep infection, iatrogenic neurovascular injuries, malunion/nonunion, amputation, death);Quality of life and functional recovery as measured by the EQ-5D instrument ;Clinical fracture healing assessed using the Functional IndeX for Trauma (FIX-IT) instrument

Countries

Rwanda

Contacts

Public ContactKiran Agarwal Harding

Assistant Professor Harvard Medical School

kahardin@bidmc.harvard.edu+16176673940

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026